Glioma
📧 Sign up to get email alerts when something new happens for Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2025-06-29Clinical Trial Update: Glioma Developmental and HyperActive Ras Tumor (DHART) Board
A clinical trial called Glioma Developmental and HyperActive Ras Tumor (DHART) is currently recruiting at Memorial Sloan Kettering Cancer Ce…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial [NA]
Clinical trial update for Proton Pulsed Reduced Dose Rate Radiotherapy (PPRDR) in recurrent CNS malignancies; the trial is currently recruit…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Diagnostic Assessment of Amino Acid PET/MRI in the Evaluation of Glioma and Brain Metastases
This clinical trial is evaluating amino acid PET/MRI for the evaluation of glioma and brain metastases. The study is currently recruiting an…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Amino Acid PET to Assess the Efficacy of IDH Inhibitor Treatments for IDH Mutated Gliomas
This clinical trial is evaluating amino acid PET as a tool to assess the efficacy of IDH inhibitor treatments in IDH-mutated gliomas; the st…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd [Phase 2]
Phase 2 trial evaluating talazoparib in combination with carboplatin for recurrent high-grade glioma with DDR deficiency has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Evaluation of the Use of a Method "Radiomics" for DOPA PET in Gliomas
A completed clinical trial evaluating radiomics analysis of DOPA PET imaging for gliomas to assess its potential utility.
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Delivery in Patients With Postoperative Recurrence of Malignant Glioma: A Single-arm Trial [Phase 2]
Phase 2 single-arm study assessing the efficacy and safety of electroacupuncture-stimulated paclitaxel delivery across the blood-brain barri…
-
EMA approval · 2025-06-02EMA Authorised: Temozolomide Accord (temozolomide) — Accord Healthcare S.L.U.
EMA authorised Temozolomide Accord (temozolomide) from Accord Healthcare S.L.U. for glioma.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis [Phase 2]
Phase 2 clinical trial evaluating whether sonodynamic therapy sensitizes brainstem glioma to radiotherapy and chemotherapy, with planned sur…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas [Phase 1]
A Phase 1 safety study of RTA 744 in patients with recurrent high-grade gliomas has completed.
-
CLINICAL_TRIALS other · 2025-05-28Clinical Trial Update: GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
Duke University's GRETeL trial evaluating tumor response to standard radiotherapy and temozolomide in glioblastoma patients has been suspend…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas [NA]
A clinical trial comparing general anesthesia versus awake surgery for resection of gliomas and brain metastases in motor cortex regions; th…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Intraoperative Sonographically Guided Resection of Non-enhancing Gliomas [NA]
The clinical trial investigating intraoperative sonographically guided resection of non-enhancing cerebral gliomas is currently suspended.
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently
This completed clinical trial evaluated functional MRI for mapping language areas in bilingual patients with glioma to aid pre-surgical plan…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors [Phase 1]
Phase 1 study evaluating panobinostat with stereotactic radiation therapy for brain tumors, including recurrent glioma, high-grade meningiom…
-
CLINICAL_TRIALS withdrawal · 2025-05-02Clinical Trial Update: Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating Glioma [NA]
A clinical trial evaluating blood-brain barrier disruption for suspected infiltrating glioma sponsored by InSightec has been withdrawn.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors [NA]
Clinical trial update on ExAblate MR-guided focused ultrasound for brain tumors, noting the study is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors [Phase 2]
Phase 2 trial of selumetinib in Neurofibromatosis type II–related tumors was terminated, with results posted in 2025; the study included ves…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients [Phase 3]
Phase 3 clinical trial comparing dapagliflozin to dexamethasone for pre-operative management in non-diabetic patients with glioma; currently…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
A Tata Memorial Centre study is investigating systemic biomarkers to predict radiation-induced neurocognitive decline in patients with brain…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: A Nomogram for Predicting the Diagnosis of Central Malignant Tumors Based on Preoperative Clinical Characteristics and Laboratory Indicators:
A completed clinical trial evaluates a nomogram based on preoperative clinical characteristics and laboratory indicators to predict diagnose…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas [Phase 2]
A Phase 2 clinical trial evaluating injections of active allogeneic natural killer cells in patients with gliomas is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Spatial and Temporal Characterization of Gliomas Using Radiomic Analysis
A Tata Memorial Centre study explores spatial and temporal radiomic analysis to characterize gliomas. The trial is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique [NA]
A clinical trial is evaluating a simultaneous dual-nuclide PET/CT imaging technique. The study is not yet recruiting and is sponsored by Xij…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: 18F-Floretyrosine Expanded Access Program
Expanded access program for the PET imaging tracer 18F-Floretyrosine is currently available for glioma patients.